Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Archives of Medical Research|September 20, 2020
Pathology-based Biomarkers Useful for Clinical Decisions in MelanomaCarlos Torres-Cabala, Elsa Li-Ning-Tapia, Wen-Jen Hwu
European Urology Oncology|December 28, 2023
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant ChemotherapyPetros Grivas, Vadim S Koshkin, Xiangying Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M Aparicio, Li Shen, Elsa Li Ning Tapia, et al.
The American Journal of Dermatopathology|May 8, 2024
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous MelanomaDebora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, et al.
The Lancet. Oncology|September 14, 2019
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trialPaul G Corn, Elisabeth I Heath, Amado Zurita, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
Pageof 1